What does Surrozen, Inc. do?
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea,…
What is Surrozen, Inc.'s P/E and P/B ratio?
Surrozen, Inc. has a P/E ratio of -0.7 and a P/B ratio of -1.38.
What is Surrozen, Inc.'s debt-to-equity ratio?
Surrozen, Inc. has a debt-to-equity ratio of -0.04.
How much does Surrozen, Inc. owe compared with what it owns?
Surrozen, Inc. owes $2.89 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Surrozen, Inc.'s Positivity rank?
Surrozen, Inc. is ranked #6,455 of 6,774 companies globally and #3,712 of 4,000 in United States on PositoAI, with a Positivity Score of -20,049.
Does Surrozen, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Surrozen, Inc..
Where can I read the latest news about Surrozen, Inc.?
Recent headlines about Surrozen, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Surrozen, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Surrozen, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.